MLYCD : malonyl-CoA decarboxylase


Description

The MLYCD (malonyl-CoA decarboxylase) is a protein-coding gene located on chromosome 16.

The MLYCD gene provides instructions for making an enzyme called malonyl-CoA decarboxylase. This enzyme helps regulate the formation and breakdown of a group of fats called fatty acids. Many tissues, including heart (cardiac) muscle, use fatty acids as a major source of energy. The body also uses fatty acids to build cell membranes, produce hormones, and carry out many other important processes. Malonyl-CoA decarboxylase is responsible for the chemical reaction that converts a molecule called malonyl-CoA to a molecule called acetyl-CoA. This reaction is an important step in the breakdown of fatty acids. Acetyl-CoA is then used to make new fatty acids and can also be used to produce energy. Malonyl-CoA decarboxylase is most active in cardiac muscle and in muscles used for movement (skeletal muscles). It is also found in other organs and tissues, including the brain, small intestine, liver, kidney, and pancreas. This enzyme probably functions in several parts of the cell, including mitochondria, which are cells' energy-producing centers, and peroxisomes, which are small sacs that process fatty acids and other molecules. Malonyl-CoA decarboxylase also functions in the fluid that surrounds these cell structures (the cytoplasm).

Catalyzes the conversion of malonyl-CoA to acetyl-CoA. In fatty acid biosynthesis, MLYCD selectively removes malonyl-CoA, ensuring that methyl-malonyl-CoA is the sole chain elongating substrate for fatty acid synthase and that fatty acids with multiple methyl side chains are produced. Within peroxisomes, it might be involved in degrading intraperoxisomal malonyl-CoA, which is generated by the peroxisomal beta-oxidation of odd chain-length dicarboxylic fatty acids. MLYCD plays a role in the metabolic balance between glucose and lipid oxidation in muscle, independent of alterations in insulin signaling. It might also play a role in controlling the extent of ischemic injury by promoting glucose oxidation.

MLYCD is also known as MCD.

Associated Diseases


Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.